Summary
Elderly hypertensive patients treated with olmesartan medoxomil demonstrated more favorable office blood pressure (BP) normalization rates and sustained 24-hour BP control compared with ramipril. This article discusses findings from the Efficacy and Safety in Elderly Patients with Olmesartan versus Ramipril Treatment [ESPORT] trial.
- Hypertensive Disease Clinical Trials
- © 2010 MD Conference Express
Tools
Olmesartan Medoxomil versus Ramipril for the Treatment of Hypertension in the Elderly
Permalink:
Table of contents
Cited By...
- No citing articles found.